{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:25:27Z","timestamp":1792085127757,"version":"4.4.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1007\/s12272-001-1275-5","type":"journal-article","created":{"date-parts":[[2008,9,19]],"date-time":"2008-09-19T13:47:47Z","timestamp":1221832067000},"page":"1098-1107","source":"Crossref","is-referenced-by-count":7,"title":["Neuroprotective effect of benzylideneacetophenone derivative on the MPTP model of neurodegeneration in mice"],"prefix":"10.1007","volume":"31","author":[{"given":"Jun Mo","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Chul","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heejeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heena","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soyong","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seikwan","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,4,30]]},"reference":[{"key":"1275_CR1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/978-1-4615-4685-6_10","volume":"468","author":"F. Aloisi","year":"1999","unstructured":"Aloisi, F., The role of microglia and astrocytes in CNS immune surveillance and immunopathology. Adv. Exp. Med. Biol., 468, 123\u2013133 (1999).","journal-title":"Adv. Exp. Med. Biol."},{"key":"1275_CR2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0301-0082(01)00003-X","volume":"65","author":"D. Blum","year":"2001","unstructured":"Blum, D., Torch, S., Lambeng, N., Nissou, M., Benabid, A. L., Sadoul, R., and Verna, J. M., Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson\u2019s disease. Prog. Neurobiol., 65, 135\u2013172 (2001).","journal-title":"Prog. Neurobiol."},{"key":"1275_CR3","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1046\/j.1471-4159.2002.00799.x","volume":"81","author":"A. Castano","year":"2002","unstructured":"Castano, A., Herrera, A. J., Cano, J., and Machado, A., The degenerative effect of a single intranigral injection of LPS on the dopaminergic system is prevented by dexamethasone, and not mimicked by rh-TNF-alpha, IL-1beta and IFN-gamma. J. Neurochem., 81, 150\u2013157 (2002).","journal-title":"J. Neurochem."},{"key":"1275_CR4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/01.WCB.0000044631.80210.3C","volume":"23","author":"Y. Chen","year":"2003","unstructured":"Chen, Y. and Swanson, R. A., Astrocytes and brain injury. J. Cereb. Blood Flow Metab., 23, 137\u2013149 (2003).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"1275_CR5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/(SICI)1096-9861(19990621)409:1<38::AID-CNE4>3.0.CO;2-1","volume":"409","author":"B. J. Ciliax","year":"1999","unstructured":"Ciliax, B. J., Drash, G. W., Staley, J. K., Haber, S., Mobley, C. J., Miller, G. W., Mufson, E. J., Mash, D. C., and Levey, A. I., Immunocytochemical localization of the dopamine transpoter in human brain. J. Comp. Neurol., 409, 38\u201356 (1999).","journal-title":"J. Comp. Neurol."},{"key":"1275_CR6","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.neures.2006.02.013","volume":"55","author":"Y. Q. Dai","year":"2006","unstructured":"Dai, Y. Q., Jin, D. Z., Zhu, X. Z., and Lei, D. L., Triptolide inhibits COX-2 expression via NF-kappa B pathway in astrocytes. Neurosci. Res., 55, 154\u2013160 (2006).","journal-title":"Neurosci. Res."},{"key":"1275_CR7","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1046\/j.1471-4159.2000.0742213.x","volume":"74","author":"T. Dehmer","year":"2000","unstructured":"Dehmer, T., Lindenau, J., Haid, S., Dichgans, J., and Schulz, J. B., Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo. J. Neurochem., 74, 2213\u20132216 (2000).","journal-title":"J. Neurochem."},{"key":"1275_CR8","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/glia.1107","volume":"36","author":"Y. Dong","year":"2001","unstructured":"Dong, Y. and Benveniste, E. N., Immune function of astrocytes. Glia, 36, 180\u2013190 (2001).","journal-title":"Glia"},{"key":"1275_CR9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0165-6147(99)01407-8","volume":"21","author":"T. Herdegan","year":"2000","unstructured":"Herdegan, T., Fischer, G., and Bold, B. G., Immunophilin ligands as a novel treatment of neurological disorders. Trends Pharmacol. Sci., 21, 3\u20135 (2000).","journal-title":"Trends Pharmacol. Sci."},{"key":"1275_CR10","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0165-0173(94)00015-H","volume":"20","author":"J. Gehrmann","year":"1995","unstructured":"Gehrmann, J., Matsumoto, Y., and Kreutzberg, G. W., Microglia: intrinsic immuneffector cell of the brain. Brain Res. Brain Res. Rev., 20, 269\u2013287 (1995).","journal-title":"Brain Res. Brain Res. Rev."},{"key":"1275_CR11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1006\/nbdi.2002.0538","volume":"11","author":"M. G. Giovannini","year":"2002","unstructured":"Giovannini, M. G., Scali, C., Prosperi, C., Bellucci, A., Vannucchi, M. G., Rosi, S., Pepeu, G., and Casamenti, F., Beta-amyloid-induced inflammation and cholinergic hypofunction in the rat brain in vivo: involvement of the p38MAPK pathway. Neurobiol. Dis., 11, 257\u2013274 (2002).","journal-title":"Neurobiol. Dis."},{"key":"1275_CR12","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/ana.410320616","volume":"32","author":"S. Fahn","year":"1992","unstructured":"Fahn, S. and Cohen, G., The oxidant stress hypothesis in Parkinson\u2019s disease: evidence supporting it. Ann. Neurol., 32, 804\u2013812 (1992).","journal-title":"Ann. Neurol."},{"key":"1275_CR13","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/j.1471-4159.2004.02399.x","volume":"89","author":"B. Ferger","year":"2004","unstructured":"Ferger, B., Leng, A., Mura, A., Hengerer, B., and Feldon, J., Genetic ablation of tumor necrosis factor-alpha (TNF-alpha) and pharmacological inhibition of TNF-synthesis attenuates MPTP toxicity in mouse striatum. J. Neurochem., 89, 822\u2013833 (2004).","journal-title":"J. Neurochem."},{"key":"1275_CR14","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejphar.2007.01.084","volume":"564","author":"X. Geng","year":"2007","unstructured":"Geng, X., Tian, X., Tu, P., and Pu, X., Neuroprotective effects of echinacoside in the mouse MPTP model of Parkinson\u2019s disease. Eur. J. Pharmacol., 564, 66\u201374 (2007).","journal-title":"Eur. J. Pharmacol."},{"key":"1275_CR15","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/BF01291788","volume":"103","author":"M. Gerlach","year":"1996","unstructured":"Gerlach, M. and Riederer, P., Animal models of Parkinson\u2019s disease: an empirical comparison with the phenomenology of the disease in man. J. Neural. Transm., 103, 987\u20131041 (1996).","journal-title":"J. Neural. Transm."},{"key":"1275_CR16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF03159727","volume":"10","author":"R. E. Heikkila","year":"1989","unstructured":"Heikkila, R. E., Sieber, B. A., Manzino, L., and Sonsalla, P. K., Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse. Mol. Chem. Neuropathol., 10, 171\u2013183 (1989).","journal-title":"Mol. Chem. Neuropathol."},{"key":"1275_CR17","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1523\/JNEUROSCI.4564-03.2004","volume":"24","author":"S. Hayley","year":"2004","unstructured":"Hayley, S., Crocker, S. J., Smith, P. D., Shree, T., Jackson-Lewis, V., Przedborski, S., Mount, M., Slack, R., Anisman, H., and Park, D. S., Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson\u2019s disease. J. Neurosci., 24, 2045\u20132053 (2004).","journal-title":"J. Neurosci."},{"key":"1275_CR18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/334345a0","volume":"334","author":"E. C. Hirsch","year":"1988","unstructured":"Hirsch, E. C., Graybiel, A. M., and Agid, Y. A., Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson\u2019s disease. Nature, 334, 345\u2013348 (1988).","journal-title":"Nature"},{"key":"1275_CR19","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1002\/ana.410440717","volume":"44","author":"E. C. Hirsch","year":"1998","unstructured":"Hirsch, E. C., Hunot, S., Damier, P., and Faucheux, B., Glial cells and inflammation in Parkinson\u2019s disease: a role in neurodegeneration? Ann. Neurol., 44, S115\u2013S120 (1998).","journal-title":"Ann. Neurol."},{"issue":"Suppl3","key":"1275_CR20","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1002\/ana.10481","volume":"53","author":"S. Hunot","year":"2003","unstructured":"Hunot, S. and Hirsch, E. C., Neuroinflammatory processes in Parkinson\u2019s disease. Ann. Neurol., 53,Suppl 3:S49\u201358; discussion S58\u201360 (2003).","journal-title":"Ann. Neurol."},{"key":"1275_CR21","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1002\/ana.410440712","volume":"44","author":"P. Jenner","year":"1998","unstructured":"Jenner, P. and Olanow, C. W., Understanding cell death in Parkinson\u2019s disease. Ann. Neurol., 44, S72\u201384 (1998).","journal-title":"Ann. Neurol."},{"key":"1275_CR22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.brainres.2006.10.089","volume":"1131","author":"J. M. Kang","year":"2007","unstructured":"Kang, J. M., Park, H. J., Choi, Y. G., Choe, I. H., Park, J. H., Kim, Y. S., and Lim, S., Acupuncture inhibits microglial activation and inflammatory events in the MPTP-induced mouse model. Brain Res., 1131, 211\u2013219 (2007).","journal-title":"Brain Res."},{"key":"1275_CR23","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0165-5728(94)90049-3","volume":"50","author":"Y. Kitamura","year":"1994","unstructured":"Kitamura, Y., Itano, Y., Kubo, T., and Nomura, Y., Suppressive effect of FK-506, a novel immunosuppressant, against MPTP-induced dopamine depletion in the striatum of young C57BL\/6 mice. J. Neuroimmunol., 50, 221\u2013224 (1994).","journal-title":"J. Neuroimmunol."},{"key":"1275_CR24","doi-asserted-by":"crossref","first-page":"6309","DOI":"10.1523\/JNEUROSCI.20-16-06309.2000","volume":"20","author":"W. G. Kim","year":"2000","unstructured":"Kim, W. G., Mohney, R. P., Wilson, B., Jeohn, G. H., Liu, B., and Hong, J, S., Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J. Neurosci., 20, 6309\u20136316 (2000).","journal-title":"J. Neurosci."},{"key":"1275_CR25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0162-3109(98)00022-8","volume":"39","author":"M. Kohutnicka","year":"1998","unstructured":"Kohutnicka, M., Lewandowska, E., Kurkowska-Jastrzebska, I., Czlonkowski, A., and Czlonkoeska, A., Microglial and astrocytic involvement in a murine model of Parkinson\u2019s disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Immunopharmacology, 39, 167\u2013180 (1998).","journal-title":"Immunopharmacology"},{"key":"1275_CR26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.pbb.2004.03.006","volume":"78","author":"R. Kurosaki","year":"2004","unstructured":"Kurosaki, R., Muramatsu, Y., Kato, H., and Araki, T., Biochemical, behavioral and immunohistochemistry alterations in MPTP-treated mouse model of Parkinson\u2019s disease. Pharmacol. Biochem. Behav., 78, 143\u2013153 (2004).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"1275_CR27","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1006\/exnr.1998.6993","volume":"156","author":"I. Kurkowska-Jastrzebska","year":"1999","unstructured":"Kurkowska-Jastrzebska, I., Wronska, A., Kohutnicka, M., Czlonkowski, A., and Czlonkowska, A., The inflammatory reaction following 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine intoxication in mouse. Exp. Neurol., 156, 50\u201361 (1999).","journal-title":"Exp. Neurol."},{"key":"1275_CR28","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","volume":"219","author":"J. W. Langston","year":"1983","unstructured":"Langston, J. W., Ballard, P., Tetrud, J. W., and Irwin, I., Chronic Parkinsonism in humans due to a product of meperidineanalog synthesis. Science, 219, 979\u2013980 (1983).","journal-title":"Science"},{"key":"1275_CR29","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/70978","volume":"5","author":"G. T. Liberatore","year":"1999","unstructured":"Liberatore, G. T., Jackson-Lewis, V., Vukosavic, S., Mandir, A.S., Vila, M., McAuliffe, W. G., Dawson, V. L., Dawson, T. M., and Przedborski, S., Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat. Med., 5, 1403\u20131409 (1999).","journal-title":"Nat. Med."},{"key":"1275_CR30","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0022-3565(24)39275-4","volume":"293","author":"B. Liu","year":"2000","unstructured":"Liu, B., Du, L., and Hong, J. S., Naloxone protects rat dopaminergic neuros against inflammatory damage through inhibition of microglia activation and superoxide generation. J. Pharmacol. Exp. Ther., 293, 607\u2013617 (2000).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"1275_CR31","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1006\/exnr.1997.6575","volume":"146","author":"K. Matsuura","year":"1997","unstructured":"Matsuura, K., Makino, H., and Ogawa, N., Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine. Exp. Neurol., 146, 526\u2013535 (1997).","journal-title":"Exp. Neurol."},{"key":"1275_CR32","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/BF02969418","volume":"29","author":"S. Oh","year":"2006","unstructured":"Oh, S., Jang, S., Kim, D., Han, I. O., and Jung, J. C., Synthesis and evaluation of biological properties of benzylideneacetophenone derivatives. Arch. Pharm. Res., 29, 469\u2013475 (2006).","journal-title":"Arch. Pharm. Res."},{"key":"1275_CR33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0165-6147(97)01146-2","volume":"19","author":"S. H. Snyder","year":"1998","unstructured":"Snyder, S. H., Sabatini, D. M., Lai, M. M., Steiner, J. P., Hamilton, G. S., and Suzdak, P. D., Neural actions of immunophilin ligands. Trends Pharmacol. Sci., 19, 21\u201326 (1998).","journal-title":"Trends Pharmacol. Sci."},{"key":"1275_CR34","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/glia.440010502","volume":"1","author":"W. J. Streit","year":"1988","unstructured":"Streit, W. J., Graeber, M. B., and Kreutzberg, G. W., Functional plasticity of microglia: a review. Glia, 1, 301\u2013307 (1988).","journal-title":"Glia"},{"key":"1275_CR35","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0006-8993(99)01209-3","volume":"824","author":"H. Tanji","year":"1998","unstructured":"Tanji, H., Araki, T., Nagasawa, H., and Itoyama, Y., Differential vulnerability of dopamine receptors in the mouse brain treated with MPTP. Brain. Res., 824, 224\u2013231 (1998).","journal-title":"Brain. Res."},{"key":"1275_CR36","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1471-4159.1993.tb13610.x","volume":"61","author":"K. F. Tipton","year":"1993","unstructured":"Tipton, K. F. and Singer, T. P., Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds. J. Neurochem., 61, 1191\u20131206 (1993).","journal-title":"J. Neurochem."},{"key":"1275_CR37","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/349414a0","volume":"349","author":"L. Turski","year":"1991","unstructured":"Turski, L., Bressler, K., Rettig, K. J., Loschmann, P. A., and Wachtel, H., Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists. Nature, 349, 414\u2013418 (1991).","journal-title":"Nature"},{"key":"1275_CR38","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2174\/1568010054022051","volume":"4","author":"S. F. Tzeng","year":"2005","unstructured":"Tzeng, S. F., Hsiao, H. Y., and Mak, O. T., Prostaglandins and cyclooxygenases in glial cells during brain inflammation. Curr Drug Targets Inflamm. Allergy, 4, 335\u2013340 (2005).","journal-title":"Curr Drug Targets Inflamm. Allergy"},{"key":"1275_CR39","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/BF01600164","volume":"418","author":"G. Viale","year":"1991","unstructured":"Viale, G., Gambacorta, M., Coggi, G., Dell\u2019Orto, P., Milani, M., and Doglioni, C., Glial fibrillary acidic protein immunoreactivity in normal and diseased human breast. Pathol. Anat. Histopathol., 418, 339\u2013348 (1991).","journal-title":"Pathol. Anat. Histopathol."},{"key":"1275_CR40","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1742-2094-3-6","volume":"3","author":"R. Vijitruth","year":"2006","unstructured":"Vijitruth, R., Liu, M., Choi, D. Y., Nguyen, X. V., Hunter, R. L., and Bing, G., Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson\u2019s disease. J. Neuroinflammation, 3, 6 (2006).","journal-title":"J. Neuroinflammation"},{"key":"1275_CR41","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1084\/jem.178.2.605","volume":"178","author":"Y. Vodovotz","year":"1993","unstructured":"Vodovotz, Y., Bogdan, C., Paik, J., Xie, Q. W., and Nathan, C., Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta. J. Exp. Med., 178, 605\u2013613 (1993).","journal-title":"J. Exp. Med."},{"key":"1275_CR42","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1096\/fj.04-2370com","volume":"19","author":"T. Wang","year":"2005","unstructured":"Wang, T., Pei, Z., Zhang, W., Liu, B., Langenbach, R., Lee, C., Wilson, B., Reece, J. M., Miller, D, S., and Hong, J. S., MPP+-induced COX-2 activation and subsequent dopaminergic neurodegeneration. FASEB J., 19, 1134\u20131136 (2005).","journal-title":"FASEB J."},{"key":"1275_CR43","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1523\/JNEUROSCI.22-05-01763.2002","volume":"22","author":"D. C. Wu","year":"2002","unstructured":"Wu, D. C., Jackson-Lewis, V., Tieu, K., Tesimann, P., Vadseth, C., Choi, D. K., Ischiropoulos, H., and Przedborski, S., Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson\u2019s disease. J. Neurosci., 22, 1763\u20131771 (2002).","journal-title":"J. Neurosci."},{"key":"1275_CR44","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1006\/exnr.1994.1079","volume":"127","author":"A. Zuddas","year":"1994","unstructured":"Zuddas, A., Fascetti, F., Corsini, G. U., and Piccardi, M. P., In brown Norway rats, MPP+ is accumulated in the nigrostriatal dopaminergic terminals but it is not neurotoxic: a model of natural resistance to MPTP toxicity. Exp. Neurol., 127, 54\u201361 (1994).","journal-title":"Exp. Neurol."}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-001-1275-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12272-001-1275-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-001-1275-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:23:10Z","timestamp":1738369390000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12272-001-1275-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["1275"],"URL":"https:\/\/doi.org\/10.1007\/s12272-001-1275-5","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}